Radius Health
Latest round
- Series B
Last raised
- Apr 2013
Total raised
- $237M
Investors
- 11
About Radius Health
Radius Health, Inc. is a biopharmaceutical company focused on developing innovative therapies for bone health and related conditions, particularly osteoporosis treatment, through its advanced product offerings. Founded in 2003, Radius Health, Inc. is based in Boston, US, and specializes in biopharmaceuticals aimed at improving bone health. The company was established by Susan Hunter, and has since undergone strategic pivots to enhance its product lineup. Radius Health, Inc. Radius Health primarily focuses on developing innovative biopharmaceutical products that target bone health and related therapeutic areas.S. in 2017 and has received supplemental FDA approval to broaden its indications. TYMLOS® is designed to treat osteoporosis in postmenopausal women, serving a critical need in a population vulnerable to bone fractures. In 2023, the company expanded its product portfolio through the exclusive licensing of BINOSTO® (alendronate sodium), a once-weekly oral bisphosphonate indicated for osteoporosis treatment. Radius Health is committed to addressing the needs of underserved patient populations, with its products primarily marketed in the United States while also exploring opportunities for partnerships and expansion into additional geographical markets. The company generates revenue through the commercialization of its patented pharmaceutical products, particularly TYMLOS® and BINOSTO®. Their business model involves direct sales to healthcare providers, pharmacies, and hospitals, establishing a B2B transaction structure that facilitates access to its medications. Radius Health is planning to further develop and launch new product lines, including enhancements to its existing offerings. They are also focused on expanding their market presence internationally, targeting Europe and Asia by 2025., a portfolio company of Gurnet Point Capital.
Who invested in Radius Health
11 investors across 11 rounds
See all investors in Radius Health
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 25, 2013
Amount
$43M
Investors
Series C
Feb 13, 2012
Amount
$21M
Investors
Series C
May 24, 2011
Amount
$66M
Investors
Series C
Nov 20, 2008
Amount
$15M
Investors
Series C
Mar 31, 2008
Amount
$28M
Investors
Series C
Aug 29, 2007
Amount
$9.9M
Investors
Series C
Mar 8, 2007
Amount
$11M
Investors
Series C
Dec 15, 2006
Amount
$18M
Investors
Series B
Dec 20, 2005
Amount
$8M
Investors
Series B
Dec 31, 2004
Amount
$8M
Investors
Series B
Nov 17, 2003
Amount
$8M
Investors
Questions about Radius Health
Who invested in Radius Health?
Radius Health has 11 investors on record across 11 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Radius Health raised?
Radius Health has raised 11 venture rounds. Sign up free to see how much each round raised and the total.
When did Radius Health last raise money?
Radius Health's most recent round on record is a Series B, in Apr 2013.
What does Radius Health do?
Radius Health is a biotechnology company.
Where is Radius Health headquartered?
Radius Health is headquartered in Boston, US.
Which VCs invest in companies like Radius Health?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Radius Health's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Radius Health? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.